Marea Therapeutics
Marea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.
Marea Therapeutics is a business in biotechnology, genetics, life science based in San Francisco Bay Area, West Coast, Western US, founded in 2022.
The company sits in the biotechnology, genetics, life science segment, where it competes on its core product or service.
San Francisco Bay Area, West Coast, Western US is where the company is located.
Directory data places it at the Series_B stage.
The company reports a headcount in the c_00001_00010 range.
It has disclosed roughly $255.4M in funding.
| Sector | Biotechnology, Genetics, Life Science |
|---|---|
| Headquarters | San Francisco Bay Area, West Coast, Western US |
| Founded | 2022 |
| Employees | c_00001_00010 |
| Stage | series_b |
| Total funding | $255,418,629 |
Website: www.mareatx.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account